Agios Pharmaceuticals Inc. (AGIO)
BMV
Closed
Aug 21, 2026
Day's Range
1,222.0052 wk Range
1,222.00Overview - AGIO - Agios Pharmaceuticals Inc.
Key Statistics
Valuation
Enterprise Value
1.22T
P/E (Trailing)
‪5.16‬
PEG Ratio
‪-0.41‬
Price / Sales (TTM)
‪741.88‬
Price / Book
‪4.19‬
EV / EBITDA
‪-159.51‬
Profitability
Gross Margin
‪93.30%‬
Profit Margin
‪88.25%‬
Operating Margin
‪-247.07%‬
Return on Assets
‪-22.24%‬
Return on Equity
‪-34.33%‬
Ownership
Shares Outstanding
59.60M
Float
50.01M
Held by Insiders
‪1.06%‬
Held by Institutions
‪112.34%‬
Price stats
Beta
‪0.58‬
50-Day Avg
‪1,222.00‬
200-Day Avg
‪1,222.00‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AGIO - Agios Pharmaceuticals Inc.
Peers - AGIO - Agios Pharmaceuticals Inc.
Peer Comparison
Compared with companies in Biotechnology listed on BMV.
- AGIOBMVAgios Pharmaceuticals Inc.72.95BMarket Cap+0.00%52-week change5.17P/E (Trailing)‪88.25%‬Profit Margin
- ARGXNBMVargenx SE American Depositary Receipt931.67BMarket Cap+4.58%52-week change33.44P/E (Trailing)‪32.26%‬Profit Margin
- ALNYBMVAlnylam Pharmaceuticals Inc742.50BMarket Cap-54.26%52-week change57.14P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNBMVBioNTech SE492.36BMarket Cap+4.53%52-week change1.65P/E (Trailing)‪-63.63%‬Profit Margin
- BMRNBMVBioMarin Pharmaceutical Inc.218.20BMarket Cap+4.43%52-week change178.64P/E (Trailing)‪2.14%‬Profit Margin
- ACADBMVAcadia Pharmaceuticals Inc.77.69BMarket Cap-12.18%52-week change13.49P/E (Trailing)‪33.41%‬Profit Margin
- ARWRBMVArrowhead Pharmaceuticals Inc.64.20BMarket Cap+0.00%52-week change-45455.00P/E (Trailing)‪-47.79%‬Profit Margin
Profile Summary - AGIO - Agios Pharmaceuticals Inc.
About
Agios Pharmaceuticals Inc. is a biopharmaceutical company specializing in cellular metabolism to develop differentiated medicines for rare diseases, with a particular emphasis on classical hematology. The company focuses on creating potentially transformative small-molecule therapies targeting unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
